text: <unk>  is an antifungal that is FDA approved for the treatment of vulvovaginal candidiasis (moniliasis).   Common adverse reactions include vulvovaginal burning, itching, headache, dysmenorrhea, abdominal pain, asthenia, Influenza-Like Illness consisting of multiple listed reactions including fever and chills, nausea, vomiting, myalgia, arthralgia, malaise, hypersensitivity, anaphylaxis, face edema, bronchospasm, rash, toxic epidermal necrolysis, urticaria.
option_0: Terconazole
option_1: Econazole
option_2: Sulconazole
option_3: Enilconazole
option_4: Betazole
option_5: Fludrocortisone acetate
option_6: Nimorazole
option_7: Dimazole